Biomarkers for Endometriosis
Recruiting now
Conditions studied: Endometriosis
In brief
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Key facts
- Study ID
- NCT07713797
- Run by
- Trio Fertility
- People needed
- 100
- Starts
- 2026-01-16
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
Where it is running
- Trio Fertility — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.